Application 220449
- Type
- NDA
- Sponsor
- BOEHRINGER INGELHEIM
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | JASCAYD | NERANDOMILAST | TABLET;ORAL | 9MG | Yes | No |
| 002 | JASCAYD | NERANDOMILAST | TABLET;ORAL | 18MG | Yes | Yes |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| JASCAYD | NERANDOMILAST | Boehringer Ingelheim Pharmaceuticals, Inc. | fa1b14c6-957f-d326-5099-911bfe33e391 | 2026-02-02 | Adverse reactions | JASCAYD NERANDOMILAST |